Big Money Sentiment decreased to 1.06 in Q4 2018. It has change of 0.12, from 2018Q3’s 1.18. The ratio fall due to Ares Capital Corporation positioning: 30 sold and 115 reduced. 49 funds bought stakes and 105 increased stakes. Investors holded 151.76 million in 2018Q3 but now own 152.67 million shares or 0.60% more.
Hudock Cap Gru Lc reported 6,900 shs or 0.04% of all its holdings. Gideon Advsrs owns 0.19% invested in Ares Capital Corporation (NASDAQ:ARCC) for 29,694 shs. Summit Secs Gp Ltd Liability holds 0.01% of its capital in Ares Capital Corporation (NASDAQ:ARCC) for 10,200 shs. 65,350 are held by Stratos Wealth Ptnrs Ltd. Pl Cap Lc holds 347,500 shs. B Riley Wealth Mngmt owns 74,333 shs. Green Square Cap Limited Liability holds 1.01% or 458,771 shs. Allsquare Wealth Management Limited Liability accumulated 23,004 shs or 0.3% of the stock. Gradient Invs Lc reported 0% stake. Brown Brothers Harriman Co accumulated 0% or 2,330 shs. 1,116 are held by Nordea Investment Management. Boston has invested 0.01% in Ares Capital Corporation (NASDAQ:ARCC). Morgan Dempsey Mngmt Llc holds 2.28% of its capital in Ares Capital Corporation (NASDAQ:ARCC) for 334,397 shs. Thrivent For Lutherans, a Minnesota-based fund reported 478,017 shs. Next Financial Group Inc Inc has 1,738 shs for 0.01% of their capital.
Ares Capital Corporation had 1 sale and 7 buys since September 20, 2018. This’s net activity of $720,290. On Wednesday, February 20 200 shs were bought by BARTLETT STEVE, worth $3,424. ROLL PENELOPE F had sold 6,000 shs worth $100,560.
Change of 13.06% for Ares Capital Corporation (NASDAQ:ARCC)’s shares shorted was recorded. In March was announced ARCC’s total 6.71 million shares shorted by FINRA. The 7.72M previous shares are down with 13.06%. Previous ARCC’s position will need 3 days to recover. It has 2.36 million average volume.
The last price was $17.48.It’s uptrending since March 13, 2018 and is 11.35% down. ARCC outperformed by 6.98% the S&P500.
Ares Capital Corporation is a business development firm specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies.The firm is valued at $7.45 billion. It also makes growth capital and general refinancing.The P/E ratio is 8.7. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care services and products, and information technology service sectors.
Ares Capital Corporation (NASDAQ:ARCC) Ratings Coverage
In total 2 analysts cover Ares Capital (NASDAQ:ARCC). “Buy” rating has 2, “Sell” are 0, while 0 are “Hold”. (NASDAQ:ARCC) has 100% bullish analysts. With $19.5 highest and $18 lowest price target, Ares Capital has $18.75 average price target or 7.27% above the current ($17.48) price. 2 are the (NASDAQ:ARCC)’s ratings reports on Mar 13, 2019 according to StockzIntelligence Inc. In Friday, February 22 report Oppenheimer initiated it with “Buy” rating and $18 target. In Wednesday, February 13 report JMP Securities maintained it with “Market Outperform” rating and $19.5 target.
For more Ares Capital Corporation (NASDAQ:ARCC) news released recently go to: Nasdaq.com, Businesswire.com, Nasdaq.com, Nasdaq.com or Globenewswire.com. The titles are as follows: “Hercules Capital’s (HTGC) Q4 Earnings Beat, Revenues Rise – Nasdaq” released on February 22, 2019, “Hercules Capital Named 2018 Specialty Finance Lender of the Year, Americas by Private Debt Investor – Business Wire” on March 04, 2019, “Zacks.com featured highlights include: Oaktree Capital, Synopsys, Starbucks, Stryker and Ares Capital – Nasdaq” with a publish date: March 08, 2019, “Thursday 1/24 Insider Buying Report: GOF, ARCC – Nasdaq” and the last “Analysis: Positioning to Benefit within Jacobs Engineering Group, Ares Capital, CytomX Therapeutics, FuelCell Energy, Timken, and Farmland Partners — Research Highlights Growth, Revenue, and Consolidated Results – GlobeNewswire” with publication date: February 20, 2019.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.